Surgical Pearls From MicroShunt Implants
Jul 28, 2021•34 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1
1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.
For the best experience, listen in Metacast app for iOS or Android